BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8146460)

  • 21. Field experiments to evaluate the feasibility of eradication of Aujeszky's disease virus by different vaccination schedules.
    De Smet K; De Waele K; Pensaert M; Goovaerts D; De Ridder E
    Vet Q; 1992 Jan; 14(1):22-8. PubMed ID: 1315465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal vaccination of pigs against Aujeszky's disease: comparison with inactivated vaccines in pigs with low maternal antibody titres.
    De Leeuw PW; Van Oirschot JT
    Res Vet Sci; 1985 Jul; 39(1):34-8. PubMed ID: 2994188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity in Aujeszky's disease virus structural glycoprotein gVI (gp50) in swine.
    Mukamoto M; Watanabe I; Kobayashi Y; Icatlo FC; Ishii H; Kodama Y
    Vet Microbiol; 1991 Oct; 29(2):109-21. PubMed ID: 1660638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of different vaccination schedules for sows to protect piglets against Aujeszky's disease.
    Casal J; Planasdemunt L; Varo JA; Martín M
    J Vet Med B Infect Dis Vet Public Health; 2004 Feb; 51(1):8-11. PubMed ID: 14995971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy of three doses of the genetically engineered Aujeszky's disease virus vaccine strain 783 in pigs with maternal antibodies.
    Kimman TG
    Vaccine; 1992; 10(6):363-5. PubMed ID: 1317982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constancy of Aujeszky's field virus antibody titres in sows repeatedly vaccinated with a gI-negative vaccine.
    Hopp W; Jungblut R
    Acta Vet Hung; 1994; 42(2-3):409-11. PubMed ID: 7810439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vaccination in Aujeszky's disease on enzootic fattening farms].
    Motovski A; Veselinova A; Shalamanov D
    Vet Med Nauki; 1980; 17(4):23-9. PubMed ID: 6259802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Plans for using vaccination in Aujeszky's disease].
    Motovski A; Veselinova A; Iordanov S; Petkova-Veselinova I
    Vet Med Nauki; 1980; 17(3):45-55. PubMed ID: 6261441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of challenge on the humoral and cellular immune responses in pseudorabies vaccinated swine.
    Alva-Valdes R; Glock RD; Kluge JP; Hill HT
    Can J Comp Med; 1983 Oct; 47(4):451-5. PubMed ID: 6321001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel concept for the control of Aujeszky's disease: experiences in two vaccinated pig herds.
    van Oirschot JT; Wijsmuller JM; de Waal CA; van Lith PM
    Vet Rec; 1990 Feb; 126(7):159-63. PubMed ID: 2155499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of passive immunity on pig immunization with deleted Aujeszky's disease vaccines measured by the amount of wild virus excretion after challenge.
    Vannier P; Hutet E; Cariolet R
    Vet Microbiol; 1995 Jan; 43(1):53-63. PubMed ID: 7716884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of an ELISA to differentiate between animals either vaccinated with or infected by Aujeszky's disease virus.
    Eloit M; Fargeaud D; Vannier P; Toma B
    Vet Rec; 1989 Jan; 124(4):91-4. PubMed ID: 2538951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody titers to pseudorabies virus in piglets immunized with gIII deleted pseudorabies vaccine in a pseudorabies infected herd.
    Elvinger F; Reeves DE; Pursell AR; Cole JR; Liauw H
    Vet Microbiol; 1994 Dec; 42(4):341-8. PubMed ID: 9133059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. gIII antibody responses in pigs following vaccination and challenge to Aujeszky's disease.
    Motha MX; Ralston JC
    Vet Microbiol; 1991 Apr; 27(2):197-201. PubMed ID: 1648283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on immunity to Aujeszky's disease (pseudorabies) virus infection in pigs.
    McFerran JB
    Dev Biol Stand; 1975; 28():563-70. PubMed ID: 165131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiplication and distribution of Aujeszky's disease (pseudorabies) virus in vaccinated and non-vaccinated pigs after intranasal infection.
    Wittmann G; Jakubik J; Ahl R
    Arch Virol; 1980; 66(3):227-40. PubMed ID: 6160831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs.
    van Rooij EM; Haagmans BL; de Visser YE; de Bruin MG; Boersma W; Bianchi AT
    Vet Immunol Immunopathol; 1998 Nov; 66(2):113-26. PubMed ID: 9860185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Field study for reduction of spread of Aujeszky's disease virus in finishing pigs with different vaccination regimes.
    Broers P; Visser N; Egger W
    Acta Vet Hung; 1994; 42(2-3):397-403. PubMed ID: 7810437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal and systemic immune responses to Aujeszky's disease virus (ADV) in early vaccinated piglets.
    Salinas-Zacarias I; Guzman-Bautista ER; Ramírez-Estudillo MDC; Chacón-Salinas R; Vega-López MA
    Comp Immunol Microbiol Infect Dis; 2020 Feb; 68():101400. PubMed ID: 31794953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Four-layer enzyme immunoassay (EIA) detection of differences in IgG, IgM and IgA antibody response to Aujeszky's disease virus in infected and vaccinated pigs.
    Rodák L; Smíd B; Valícek L; Jurák E
    Vet Microbiol; 1987 Feb; 13(2):121-33. PubMed ID: 3031872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.